Press releases | Finanzwire

Basculer en Français

10278	Companies
212787	Keywords
142571	Articles
112672	Press releases

Home
Press releases

PRESS RELEASE

published on 09/17/2025 at 14:30, 7 months 7 days ago

NioCorp Announces Pricing of $50.0 Million Registered Direct Offering of Common Shares
NioCorp Developments Ltd. announces a registered direct offering of common shares in the United States, expected to raise approximately $50.0 million for corporate purposes and Elk Creek Project advancement

Securities Elk Creek Project NioCorp Financial Direct Offering
PRESS RELEASE

published on 09/17/2025 at 14:15, 7 months 7 days ago

Capgemini obtains all regulatory approvals for the acquisition of WNS
Capgemini obtains all regulatory approvals for the acquisition of WNS. Transaction remains pending court sanction for Scheme of Arrangement. Closing expected by end of October 2025

Acquisition Regulatory Approvals Capgemini Scheme Of Arrangement WNS
PRESS RELEASE

published on 09/17/2025 at 14:00, 7 months 7 days ago

SMX and REDWAVE Prove Recycling's Greatest Transformation Is Here (NASDAQ: SMX)
SMX and REDWAVE showcase groundbreaking recycling technology with high-speed detection and certification of various plastics, revolutionizing global material economics

Recycling Certification Plastics SMX REDWAVE
PRESS RELEASE

published on 09/17/2025 at 14:00, 7 months 7 days ago

Karbon-X Corp. Files Year-End Financial Results
Karbon-X Corp. announces filing of Form 10-K for fiscal year 2025, showcasing revenue growth and strategic achievements. Company strengthens global presence and partnerships

Revenue Growth Partnerships Form 10-K Climate Solutions Karbon-X Corp.
PRESS RELEASE

published on 09/17/2025 at 14:00, 7 months 7 days ago

Protagonist Announces Presentations of Clinical Data with Icotrokinra in Plaque Psoriasis and Preclinical Data with PN-881 at the EADV 2025 Congress
Protagonist Therapeutics announces superior skin clearance data for icotrokinra compared to deucravacitinib and sustained clearance in ICONIC-LEAD study. Preclinical data on PN-881 presented at EADV Congress 2025

Preclinical Data Protagonist Therapeutics Phase 3 Studies Icotrokinra Skin Clearance
PRESS RELEASE

published on 09/17/2025 at 14:00, 7 months 7 days ago

Prince Silver Commences Fully Funded Drill Program at the Prince Silver Project in Nevada
Prince Silver Corp. announces commencement of a fully funded 6,500-meter exploration drill program at flagship silver project, aiming to expand high-grade zones and validate historical drilling

Exploration Drill Program Nevada High-grade Zones Mineralized System Prince Silver Corp.
PRESS RELEASE

published on 09/17/2025 at 14:00, 7 months 7 days ago

Inside Information / Other news releases
Medincell and Teva to discuss Phase 3 Olanzapine LAI data from SOLARIS Trial at 2025 Psych Congress. Webcast details available on Teva's IR website

Phase 3 Medincell Teva SOLARIS Trial Olanzapine LAI
PRESS RELEASE

published on 09/17/2025 at 13:58, 7 months 7 days ago

Amundi Physical Metals plc: Final Terms
Amundi Physical Metals plc issues 34,000 ETC Securities of Amundi Physical Gold ETC Tranche 749 with Metal Entitlement of 0.03965694 fine troy ounces. The ETC Securities are linked to the price of Gold and listed on multiple stock exchanges

Stock Exchanges Amundi Physical Metals Plc ETC Securities Gold Price Tranche 749
PRESS RELEASE

published on 09/17/2025 at 13:54, 7 months 7 days ago

Amundi Physical Metals plc: UK Final Terms
Amundi Physical Metals plc issues Final Terms for 34,000 ETC Securities of Amundi Physical Gold ETC Series 749 under Secured Precious Metal Linked ETC Securities Programme

Amundi Physical Metals Plc ETC Securities Final Terms Secured Precious Metal Gold ETC Series 749
PRESS RELEASE

published on 09/17/2025 at 13:48, 7 months 7 days ago

Marinomed Biotech AG announces results for the first half year of 2025
Marinomed Biotech AG reports strong financial results for the first half of 2025, with revenues of EUR 7.2 million and EBIT of EUR 21.0 million. The company secured financing through capital measures

Revenues Financial Results EBIT Marinomed Biotech AG Capital Measures

Accesswire

Published on 04/24/2026 at 15:00, 29 minutes ago

Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 29 minutes ago

First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/24/2026 at 14:30, 59 minutes ago

Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
Published on 04/24/2026 at 14:00, 1 hour 29 minutes ago

Datametrex Expands Patent Monetization Strategy Adding Quantum-Resilient Encryption Technologies
Published on 04/24/2026 at 13:30, 1 hour 59 minutes ago

Alset AI Announces Closing of Second Tranche of Loan Transaction of up to $3 Million

View all ACCESSWIRE

EQS Group

Published on 04/24/2026 at 15:01, 27 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 04/24/2026 at 15:01, 28 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 04/24/2026 at 14:25, 1 hour 3 minutes ago

PRESIDENT SAMIA RECEIVES COMMISSION OF INQUIRY REPORT; CALLS FOR NATIONAL HEALING, ACCOUNTABILITY AND REFORMS
Published on 04/24/2026 at 13:07, 2 hours 21 minutes ago

Cantourage Group SE: U.S. Cannabis Rescheduling Highlights Global Growth Potential – Europe Comes into Focus
Published on 04/24/2026 at 12:53, 2 hours 35 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: Preparation of measures to return proceeds from the sale of the Bikeleasing Group to shareholders; postponement of the 2026 Annual General Meeting

Les Echos

Published on 04/23/2026 at 19:27, 20 hours 1 minute ago

Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 21 hours 10 minutes ago

Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
Published on 04/23/2026 at 18:00, 21 hours 28 minutes ago

First-quarter 2026 Sales
Published on 04/23/2026 at 18:00, 21 hours 29 minutes ago

2025 Full-Year Results: Strong Top-Line Rebound (+26%)
Published on 04/23/2026 at 17:50, 21 hours 39 minutes ago

Cegedim: Like-for-like revenues fell 0.8% in the first quarter of 2026

View all LES ECHOS COMFI WIRE